Personalized Nutritional Strategies to Reduce Knee Osteoarthritis Severity and Ameliorate Sarcopenic Obesity Indices: A Practical Guide in an Orthopedic Setting

Nutrients. 2023 Jul 9;15(14):3085. doi: 10.3390/nu15143085.

Abstract

Knee osteoarthritis (KOA) is one of the most common joint diseases, especially in individuals with obesity. Another condition within this population, and which presents frequently, is sarcopenic obesity (SO), defined as an increase in body fat and a decrease in muscle mass and strength. The current paper aims to describe recent nutritional strategies which can generally improve KOA clinical severity and, at the same time, ameliorate SO indices. Searches were carried out in the PubMed and Science Direct databases and data were summarized using a narrative approach. Certain key findings have been revealed. Firstly, the screening and identification of SO in patients with KOA is important, and to this end, simple physical performance tests and anthropometric measures are available in the literature. Secondly, adherence to a Mediterranean diet and the achievement of significant body weight loss by means of low-calorie diets (LCDs) remain the cornerstone nutritional treatment in this population. Thirdly, supplementation with certain micronutrients such as vitamin D, essential and non-essential amino acids, as well as whey protein, also appear to be beneficial. In conclusion, in the current review, we presented a detailed flowchart of three different nutritional tracks that can be adopted to improve both KOA and SO based on joint disease clinical severity.

Keywords: body composition; body lean mass; fat distribution; muscle mass; muscle strength; obesity; osteoarthritis; sarcopenic obesity; skeletal muscle mass; total body fat.

Publication types

  • Review

MeSH terms

  • Body Composition / physiology
  • Humans
  • Muscle, Skeletal / metabolism
  • Obesity / complications
  • Obesity / epidemiology
  • Obesity / therapy
  • Osteoarthritis, Knee* / diagnosis
  • Osteoarthritis, Knee* / therapy
  • Sarcopenia* / epidemiology

Grants and funding

This research received no external funding.